JP2023076465A5 - - Google Patents

Download PDF

Info

Publication number
JP2023076465A5
JP2023076465A5 JP2023034704A JP2023034704A JP2023076465A5 JP 2023076465 A5 JP2023076465 A5 JP 2023076465A5 JP 2023034704 A JP2023034704 A JP 2023034704A JP 2023034704 A JP2023034704 A JP 2023034704A JP 2023076465 A5 JP2023076465 A5 JP 2023076465A5
Authority
JP
Japan
Prior art keywords
formulation
dexmedetomidine
minutes
subject
insomnia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023034704A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023076465A (ja
Filing date
Publication date
Priority claimed from JP2021025810A external-priority patent/JP2021080276A/ja
Application filed filed Critical
Publication of JP2023076465A publication Critical patent/JP2023076465A/ja
Publication of JP2023076465A5 publication Critical patent/JP2023076465A5/ja
Priority to JP2025030902A priority Critical patent/JP2025092508A/ja
Pending legal-status Critical Current

Links

JP2023034704A 2014-10-15 2023-03-07 デクスメデトミジン製剤を使用する睡眠障害の予防または治療 Pending JP2023076465A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025030902A JP2025092508A (ja) 2014-10-15 2025-02-28 デクスメデトミジン製剤を使用する睡眠障害の予防または治療

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462064205P 2014-10-15 2014-10-15
US62/064,205 2014-10-15
JP2021025810A JP2021080276A (ja) 2014-10-15 2021-02-22 デクスメデトミジン製剤を使用する睡眠障害の予防または治療

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021025810A Division JP2021080276A (ja) 2014-10-15 2021-02-22 デクスメデトミジン製剤を使用する睡眠障害の予防または治療

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025030902A Division JP2025092508A (ja) 2014-10-15 2025-02-28 デクスメデトミジン製剤を使用する睡眠障害の予防または治療

Publications (2)

Publication Number Publication Date
JP2023076465A JP2023076465A (ja) 2023-06-01
JP2023076465A5 true JP2023076465A5 (enExample) 2024-03-25

Family

ID=55747372

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017520539A Pending JP2017534613A (ja) 2014-10-15 2015-10-15 デクスメデトミジン製剤を使用する睡眠障害の予防または治療
JP2021025810A Pending JP2021080276A (ja) 2014-10-15 2021-02-22 デクスメデトミジン製剤を使用する睡眠障害の予防または治療
JP2023034704A Pending JP2023076465A (ja) 2014-10-15 2023-03-07 デクスメデトミジン製剤を使用する睡眠障害の予防または治療
JP2025030902A Pending JP2025092508A (ja) 2014-10-15 2025-02-28 デクスメデトミジン製剤を使用する睡眠障害の予防または治療

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2017520539A Pending JP2017534613A (ja) 2014-10-15 2015-10-15 デクスメデトミジン製剤を使用する睡眠障害の予防または治療
JP2021025810A Pending JP2021080276A (ja) 2014-10-15 2021-02-22 デクスメデトミジン製剤を使用する睡眠障害の予防または治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025030902A Pending JP2025092508A (ja) 2014-10-15 2025-02-28 デクスメデトミジン製剤を使用する睡眠障害の予防または治療

Country Status (5)

Country Link
US (3) US20170239221A1 (enExample)
EP (1) EP3206685B1 (enExample)
JP (4) JP2017534613A (enExample)
MA (1) MA41689A (enExample)
WO (1) WO2016061413A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3562486B1 (en) * 2016-12-31 2024-03-13 Bioxcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
CN114983979A (zh) 2018-06-27 2022-09-02 比奥克斯塞尔医疗股份有限公司 含右美托咪定的膜制剂及其制造方法
JP7739256B2 (ja) 2019-07-19 2025-09-16 バイオエクセル セラピューティクス，インコーポレイテッド 鎮静作用のないデクスメデトミジン治療レジメン
CN118948739A (zh) * 2020-06-08 2024-11-15 四川普锐特药业有限公司 右美托咪定滴鼻剂或鼻喷剂在助眠药物制备中的应用
AU2022239873A1 (en) 2021-03-19 2023-11-02 Orion Corporation Tasipimidine formulations and use thereof
CN115197149B (zh) * 2021-04-02 2023-09-22 四川大学华西医院 一种5-苄基咪唑类化合物及其制备方法和用途
JP7778911B2 (ja) * 2021-08-23 2025-12-02 イーチャン・ヒューマンウェル・ファーマシューティカルズ・カンパニー・リミテッド デクスメデトミジン経皮組成物、経皮貼付剤及びその調製方法、適用
WO2024023261A1 (en) 2022-07-27 2024-02-01 Universität Zürich Dexmedetomidine for the treatment of sleep disorders
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
KR102853305B1 (ko) * 2023-05-25 2025-09-01 가톨릭대학교 산학협력단 상추 추출물 및 대추 추출물을 유효성분을 함유하는 불면증 해소용 구강 붕해 필름 조성물
CN117771220B (zh) * 2024-02-28 2024-05-28 山东第二医科大学 一种右美托咪定中药多糖口溶膜剂及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030022926A1 (en) * 2001-05-07 2003-01-30 Lavand'homme Patricia Method for treating neuropathic pain and pharmaceutical preparation therefor
US20050222270A1 (en) * 2004-02-26 2005-10-06 Olney John W Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis
JP2008514612A (ja) * 2004-09-23 2008-05-08 ミシャロウ、アレクサンダー 対抗適応を誘発することにより神経伝達物質系を調節する方法
US7378508B2 (en) * 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
US20090076156A1 (en) * 2005-07-18 2009-03-19 Masud Husain Use of a noradrenergic agonist, e.g. guanfacine, for the treatment of cognitive disorders
DK1986642T3 (da) * 2006-02-13 2014-02-03 Orient Pharma Samoa Co Ltd Kombination af alfa-2-receptoragonist (clonidin) og et antimuscarinmiddel (oxybutynin) til behandling af sialorrhoea
US20100028447A1 (en) * 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
WO2008141264A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
US20100196286A1 (en) * 2008-12-01 2010-08-05 Armer Thomas A Inhalation delivery methods and devices
RU2572692C2 (ru) * 2009-05-15 2016-01-20 Рекро Фарма, Инк. Сублингвальные композиции дексмедетомидина и способы их применения
CN102753169A (zh) * 2010-01-08 2012-10-24 瑞克欧制药有限公司 外用透皮右美托咪啶组合物及其应用方法
US8241661B1 (en) * 2011-06-24 2012-08-14 Fuisz Richard C Biocompatible film with variable cross-sectional properties
WO2013061161A2 (en) * 2011-10-28 2013-05-02 Green Bcn Consulting Services Sl New combination therapies for treating neurological disorders
CA2858721C (en) * 2011-12-11 2021-03-16 Recro Pharma, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
TWI709417B (zh) * 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物

Similar Documents

Publication Publication Date Title
JP2023076465A5 (enExample)
JP2025092508A5 (enExample)
JP2023041862A5 (enExample)
JP2006523216A5 (enExample)
JP2009514874A5 (enExample)
JP2019503365A5 (enExample)
JP2017528507A5 (enExample)
JP2022191257A5 (enExample)
ATE350040T1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
JP2022163049A5 (enExample)
JP2014518252A5 (enExample)
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
BRPI0711168A2 (pt) composição transmucosal
JP2007533687A5 (enExample)
JP2017535613A5 (enExample)
Aufdemorte et al. Griseofulvin in the treatment of three cases of oral erosive lichen planus
RS51452B (sr) Orodisperzivne farmaceutske smeše za oralnu, oromukozalnu ili sublingvalnu primenu agomelatina
JP2008542299A5 (enExample)
JP2020529995A5 (enExample)
JP2019218379A5 (enExample)
JP2019514990A5 (enExample)
JP2011500589A5 (enExample)
JP2019507786A5 (enExample)
CN104225246A (zh) 一种口腔溃疡膜剂及其制备方法
JP2003503453A5 (ja) ガバペンチンおよびプレガバリンを含む相乗作用組成物